Medical device company Topera has raised $25 million in a Series C round of financing from lead investor New Enterprise Associates. Based in San Diego, the company has developed mapping catheters and a computational analysis system for the identification of sources that sustain cardiac arrhythmias. Proceeds from the round will go primarily towards the commercial launch of the company’s products and to further advance its R&D pipeline and clinical development program. The round also saw participation from individual investors. Joining Topera’s Board of Directors in conjunction with the financing is NEA partner Justin Klein.